loading...| Preferred Name |
erythromycin |
|
| Synonyms |
Ilotycin |
|
| Definitions |
A broad-spectrum, topical macrolide antibiotic with antibacterial activity. Erythromycin diffuses through the bacterial cell membrane and reversibly binds to the 50S subunit of the bacterial ribosome. This prevents bacterial protein synthesis. Erythromycin may be bacteriostatic or bactericidal in action, depending on the concentration of the drug at the site of infection and the susceptibility of the organism involved. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C476" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C476" NCI Thesaurus) |
|
| ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000039234 |
|
| altLabel |
Ilotycin ERYC RP-Mycin Ery-Tab Robimycin E-Mycin |
|
| CAS Registry |
114-07-8 |
|
| cui |
C0699348 C0699344 C0699340 C0699345 C0014806 C0699339 C0699341 |
|
| definition |
A broad-spectrum, topical macrolide antibiotic with antibacterial activity. Erythromycin diffuses through the bacterial cell membrane and reversibly binds to the 50S subunit of the bacterial ribosome. This prevents bacterial protein synthesis. Erythromycin may be bacteriostatic or bactericidal in action, depending on the concentration of the drug at the site of infection and the susceptibility of the organism involved. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C476" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C476" NCI Thesaurus) |
|
| Legacy PDQ ID |
1856 |
|
| LT |
TRD |
|
| NCI ID |
C476 |
|
| notation |
CDR0000039234 |
|
| NSC Code |
55929 |
|
| ORIG STY |
Drug/agent |
|
| prefLabel |
erythromycin |
|
| tui |
T109 T195 |